References
- Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 1992; 128:702
- Price VH. Alopecia areata: Clinical aspects. J Invest Dermatol 1991; 96:68
- Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005; 331:951 - 953
- De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM. Juvenile versus maturity-onset alopecia areata—A comparative retrospective clinical study. Clin Exp Dermatol 1989; 14:429 - 436
- Friedmann PS. Alopecia areata and autoimmunity. Br J Dermatol 1981; 105:153 - 157
- Muller SA, Winkelman RK. Alopecia areata: An evaluation of 736 patients. Arch Dermatol 1963; 88:290 - 297
- Gilhar A, Kalish RS. Alopecia areata: A tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006; 5:64 - 69
- Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969; 81:877 - 881
- Gilhar A, Krueger GG. Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch Dermatol 1987; 123:44 - 50
- Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998; 101:62 - 67
- Ross EK, Shapiro J. Management of hair loss. Dermatol Clin 2005; 23:227 - 243
- MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149:692 - 699
- Winter RJ, Kern F, Blizzard RM. Prednisone therapy for alopecia areata: a follow-up report. Arch Dermatol 1976; 112:1549 - 1552
- Dillaha CJ, Rothman S. Therapeutic experiments in alopecia areata with orally administered cortisone. JAMA 1952; 150:546 - 550
- Kern F, Hoffmann WH, Hambrick GW Jr, Blizzard RM. Alopecia areata: immunologic studies and treatment with prednisone. Arch Dermatol 1973; 107:407 - 412
- Fisher DA. Systemic steroids for treatment of alopecia areata. Arch Dermatol 1977; 113:1731 - 1732
- Unger WP, Schemmer RJ. Corticosteroids in the treatment of alopecia totalis: systemic effects. Arch Dermatol 1978; 114:1486 - 1490
- Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992; 128:1467 - 1473
- Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005; 52:287 - 290
- Burton JL, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 1975; 55:493 - 496
- Ikeda T. A new classification of alopecia areata. Dermatologica 1965; 131:421
- Perriand-Wolfensberger J, Pasche-Koo F, Mainetti C, Labarthe MP, Salomon D, Saurat JH. Pulse of methylprednisolon in alopecia areata. Dermatology 1993; 187:282 - 285
- Kiesch N, Stene JJ, Goens J, Vanhooteghem O, Song M. Pulse steroid therapy for children's severe alopecia areata?. Dermatology 1997; 194:395 - 397
- Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolon therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998; 39:597 - 602
- Seiter S, Ugurel S, Tilgen W, Reinhold U. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2002; 101:223 - 226
- Tsai YM, Chen W, Hsu ML, Lin TK. High-dose steroid pulse therapy for the treatment of severe alopecia areata. J Formos Med Assoc 2001; 101:223 - 226
- Assouly P, Reygagne P, Jouanique C, Matard B, Marechal E, Reynert P, et al. Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients. Ann Dermatol Venereol 2003; 326 - 330
- Luggen P, Hunziker T. High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature. J Dtsch Dermatol Ges 2008; 6:375 - 378
- Sladden MJ, Hutchinson PE. Is oral pulsed prednisolone useful in alopecia areata? Critical appraisal of a randomized trial. J Am Acad Dermatol 2005; 53:1100 - 1101